CN Patent

CN108368139B — 取代的恶唑烷酮化合物及其应用

Assigned to Shenzhen Targetrx Inc · Expires 2020-12-18 · 5y expired

What this patent protects

式(I)所示的恶唑烷酮化合物，或其晶型、药学上可接受的盐、前药、代谢物、立体异构体、同位素变体、水合物或溶剂合物，包含该化合物的药物组合物。该化合物显示对广谱菌的抑制活性和低毒性，可作为抗生素。

USPTO Abstract

式(I)所示的恶唑烷酮化合物，或其晶型、药学上可接受的盐、前药、代谢物、立体异构体、同位素变体、水合物或溶剂合物，包含该化合物的药物组合物。该化合物显示对广谱菌的抑制活性和低毒性，可作为抗生素。

Drugs covered by this patent

Patent Metadata

Patent number
CN108368139B
Jurisdiction
CN
Classification
—
Expires
2020-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Targetrx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.